Subscribe
brexit-istock-537519806_andrewlinscott
andrewlinscott / iStockphoto.com
16 July 2018Big Pharma

Brexit plan reassuring for pharma industry, but uncertainties remain: lawyers

While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
UK shares Brexit implementation plans for life sciences
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.
Big Pharma
Parliament votes for UK to stay in EMA
23 July 2018   The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

More on this story

Big Pharma
UK shares Brexit implementation plans for life sciences
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.
Big Pharma
Parliament votes for UK to stay in EMA
23 July 2018   The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

More on this story

Big Pharma
UK shares Brexit implementation plans for life sciences
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.
Big Pharma
Parliament votes for UK to stay in EMA
23 July 2018   The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?